New genetic variations linked to schizophrenia
Researchers have used Affymetrix Genome-Wide Human SNP (single nucleotide polymorphism) arrays to discover genetic variations that increase the risk of schizophrenia.
Archives for August 17, 2008
Contract research news in brief
in-PharmaTechnologist.com presents its round up of the latest developments in contract research, including CTI partnering to access Latin America, Encorium signing contracts worth $13.5m and Omnicare setting up in Sweden.
Vaccine sales help Crucell cut Q2 loss
An increase in the sale of vaccines such as Quinvaxem and Epaxal, helped Dutch drugmaker Crucell reduce its loss some 56 per cent to €7.9m ($12.5m) in the second quarter.
Qiagen records strong revenue growth in Q2
Dutch assay experts Qiagen reported a 61 per cent jump in revenues helped by its $1.6bn (€1.07bn) acquisition of Digene towards the end of last year.
Bio-Rad’s revenues and profits soar
Bio-Rad has reported second-quarter revenue growth of 33 per cent due to its acquisition of laboratory diagnostics firm DiaMed and strong organic growth.
HGS enlists Eden for client indentification
UK-based Eden Biodesign has been selected as marketing services partner for US drug developer Human Genome Sciences (HGS).
AgenoLab first to install Roche’s new assay platform
German biotech and life science laboratory services firm AgenoLab has installed the first xCelligence real-time cell analysis system to bolster its assay offering to customers.
Manufacturing facility news in brief
in-PharmaTechnologist.com's round-up of developments in pharmaceutical manufacturing features news of SAFC’s new highly potent API plant, ISPE’s Facility of the Year Awards and Israel’s proposed entry into PIC/S.
Advalytix amplifies the importance single cell analysis
Advalytix’ AmpliGrid technology is playing a key role in enabling researchers to discover how just a single cell can lay a huge role in complex biological systems.